John Varian
Director/Board Member bei SELLAS LIFE SCIENCES GROUP, INC.
Vermögen: 10 504 $ am 31.03.2024
Profil
John W.
Varian is currently an Independent Director at Acorda Therapeutics, Inc. and Sellas Life Sciences Group Ltd.
He is also a Director at SELLAS Life Sciences Group, Inc., AmMax Bio, Inc., and a Founding Member at The Bay Area.
Previously, he served as the Chief Executive Officer & Director at XOMA Corp.
from 2011 to 2016.
He was also the Chairman of The Association of Bioscience Financial Officers.
Additionally, he held positions such as Director at Zyla Life Sciences LLC, Independent Director at Versartis, Inc., Chief Financial Officer at Neurex Corp., Chief Financial Officer & Vice President-Finance at Anergen, Inc., Chief Financial Officer at Serono Genetics Institute SA, Chief Operating & Financial Officer at Nventa Biopharmaceuticals Corp., Senior Vice President-Finance & Administration at Elan Pharmaceuticals LLC, Audit Principal & Senior Manager at Ernst & Young LLP (Missouri), and Chief Financial Officer at Gen Set SpA.
He served as the Chief Operating & Financial Officer at ARYx Therapeutics, Inc. from 2003 to 2011.
Mr. Varian obtained his undergraduate degree from Western Michigan University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.01.2024 | 10 400 ( 0,02% ) | 10 504 $ | 31.03.2024 | |
| 22.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von John Varian
| Unternehmen | Position | Beginn |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Director/Board Member | 29.12.2017 |
| ACORDA THERAPEUTICS, INC. | Director/Board Member | 01.01.2022 |
AmMax Bio, Inc.
 AmMax Bio, Inc. BiotechnologyHealth Technology AmMax Bio, Inc. is a clinical stage biotech company. The private company is based in Redwood City, CA. The CEO of the company is Chung Chiang Hsu. | Director/Board Member | - |
Sellas Life Sciences Group Ltd.
 Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Director/Board Member | 29.12.2017 |
The Bay Area
 The Bay Area BiotechnologyHealth Technology The Bay Area provides biomedical advocacy services. The private company is based in San Francisco, CA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von John Varian
| Unternehmen | Position | Ende |
|---|---|---|
| ZYLA LIFE SCIENCES | Director/Board Member | 01.02.2019 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Director/Board Member | 12.10.2018 |
| XOMA CORPORATION | Chief Executive Officer | 21.12.2016 |
| ARYX THERAPEUTICS, INC. | Director of Finance/CFO | 01.08.2011 |
| ░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von John Varian
| Western Michigan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| XOMA CORPORATION | Health Technology |
| ACORDA THERAPEUTICS, INC. | Health Technology |
| ARYX THERAPEUTICS, INC. | Health Technology |
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Private Unternehmen | 14 |
|---|---|
Neurex Corp.
 Neurex Corp. Pharmaceuticals: MajorHealth Technology Neurex Corporation is a developmental biopharmaceutical company focused on acute care therapeutics for the treatment of diverse neurological and cardiovascular indications. | Health Technology |
| Anergen, Inc. | Health Technology |
Serono Genetics Institute SA
 Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The private company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Commercial Services |
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Health Technology |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Ernst & Young provides accounting services. Its services include auditing, accounting, tax and transaction services, assurance and advisory business, online transaction advisory and a wide range of financial services. The company was founded by Arthur Young and Alwin C. Ernst in 1881 and is headquartered in Kansas City, MO. | Commercial Services |
Gen Set SpA
 Gen Set SpA Electrical ProductsProducer Manufacturing Gen Set SpA manufactures portable generators. Its products include industrail generators, special applications, welding, veicolar generators, and light towers. The company was founded by Pascal Brandys in 1974 and is headquartered in Villanova d'Ardenghi, Italy. | Producer Manufacturing |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Commercial Services |
The Bay Area
The Bay Area BiotechnologyHealth Technology The Bay Area provides biomedical advocacy services. The private company is based in San Francisco, CA. | Health Technology |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
SELLAS Life Sciences Group, Inc. /Old/
 SELLAS Life Sciences Group, Inc. /Old/ BiotechnologyHealth Technology SELLAS Life Sciences Group, Inc. /Old/ is based in New York, NY. SELLAS Life Sciences Group, Inc. is a clinical-stage biopharmaceutical company. | Health Technology |
AmMax Bio, Inc.
AmMax Bio, Inc. BiotechnologyHealth Technology AmMax Bio, Inc. is a clinical stage biotech company. The private company is based in Redwood City, CA. The CEO of the company is Chung Chiang Hsu. | Health Technology |
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Health Technology |
